| 1 |
Abrams SA, Hawthorne KM, Pammi M. A systematic review of controlled trials of lower-protein or energy- containing infant formulas for use by healthy full-term infants. Adv Nutr 2015;6:178-88./
|
|
| 2 |
Ziegler EE, Fields DA, Chernausek SD, Steenhout P, Grathwohl D, Jeter JM, et al. Adequacy of infant formula with protein content of 1.6 g/100 kcal for infants between 3 and 12 months. J Pediatr Gastroenterol Nutr 2015;61:596-603./
|
|
| 3 |
Albuquerque D, Stice E, Rodriguez-Lopez R, Manco L, Nobrega C. Current review of genetics of human obesity: from molecular mechanisms to an evolutionary perspective. Mol Genet Genomics 2015;290:1191-221./
|
|
| 4 |
Pineton de Chambrun G, Desreumaux P, Cortot A. Eosinophilic enteritis. Dig Dis 2015;33:183-9./
|
|
| 5 |
Lucendo AJ, Serrano-Montalban B, Arias A, Redondo O, Tenias JM. Efficacy of dietary treatment for inducing disease remission in eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr 2015;61:56-64./
|
|
| 6 |
Uotani T, Graham DY. Diagnosis of Helicobacter pylori using the rapid urease test. Ann Transl Med 2015;3:9./
|
|
| 7 |
MacFabe DF. Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders. Microb Ecol Health Dis 2015;26:28177./
|
|
| 8 |
Wen T, Dellon ES, Moawad FJ, Furuta GT, Aceves SS, Rothenberg ME. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol 2015;135:187-97./
|
|
| 9 |
Lindor KD, Kowdley KV, Harrison ME; American College of Gastroenterology. ACG Clinical Guideline: primary sclerosing cholangitis. Am J Gastroenterol 2015;110:646-59; quiz 660./
|
|
| 10 |
Schrumpf E, Boberg KM, Karlsen TH. Primary sclerosing cholangitis - the Norwegian experience. Scand J Gastroenterol 2015;50:781-96./
|
|